These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7051238)

  • 1. Use of trimethoprim alone or in combination with drugs other than sulfonamides.
    Brumfitt W; Hamilton-Miller JM
    Rev Infect Dis; 1982; 4(2):402-10. PubMed ID: 7051238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled clinical trial of a rifampicin- trimethoprim combination (Rifaprim) and cotrimoxazole in patients with chronic urinary tract infections.
    Adachi T; de Almeida TR
    J Int Med Res; 1979; 7(2):132-7. PubMed ID: 383553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifaprim in urinary tract infection: a comparison with co-trimoxazole.
    Kosmidis J; Giamarellou H; Papadakis M; Eliades E; Daikos GK
    J Antimicrob Chemother; 1983 Mar; 11(3):239-44. PubMed ID: 6601648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
    Smellie JM; Grüneberg RN; Normand IC; Bantock HM
    Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole and other sulfonamides.
    Foltzer MA; Reese RE
    Med Clin North Am; 1987 Nov; 71(6):1177-94. PubMed ID: 3320619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.
    Bodey GP; Grose WE; Keating MJ
    Rev Infect Dis; 1982; 4(2):579-85. PubMed ID: 6981174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole in treatment of severe infections.
    Salter AJ
    Rev Infect Dis; 1982; 4(2):338-50. PubMed ID: 7051234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
    Young LS; Hindler J
    Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphonamides and trimethoprim.
    Reeves D
    Lancet; 1982 Aug; 2(8294):370-3. PubMed ID: 6124767
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations.
    Burman LG
    Scand J Infect Dis; 1986; 18(2):89-99. PubMed ID: 3518051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control.
    Stamm WE; Counts GW; McKevitt M; Turck M; Holmes KK
    Rev Infect Dis; 1982; 4(2):450-5. PubMed ID: 6981163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
    Overturf GD
    Rev Infect Dis; 1987; 9 Suppl 2():S168-76. PubMed ID: 3554455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole.
    Hughes WT
    Pediatr Clin North Am; 1983 Feb; 30(1):27-30. PubMed ID: 6600834
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications.
    Gleckman R; Blagg N; Joubert DW
    Pharmacotherapy; 1981; 1(1):14-20. PubMed ID: 6985448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.